8-Nitroguanine as a potential biomarker for progression of malignant fibrous histiocytoma, a model of inflammation-related cancer

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1165-1169

  Hoki, Yoko ^a   Murata, Mariko ^a   Hiraku, Yusuke ^a   Ma, Ning ^a   Matsumine, Akihiko ^a   Uchida, Atsumasa ^a   Kawanishi, Shosuke ^a,b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

8 nitroguanine; Carcinogenesis; DNA damage; Hypoxia; Hypoxia inducible factor 1 ; Inflammation; Malignant fibrous histiocytoma; Prognosis; Tumor progression

Indexed keywords

8 NITROGUANINE; 8-NITROGUANINE; AUTACOID; DRUG DERIVATIVE; GUANINE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METABOLISM; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GUANINE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NF-KAPPA B; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 38449111153     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
2. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001. (Pubitemid 32173595)
3. Hussain SP, Hofseth LJ and Harris CC: Radical causes of cancer. Nat Rev Cancer 3: 276-285, 2003. (Pubitemid 37328863)
4. Ohshima H, Tatemichi M and Sawa T: Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417: 3-11, 2003. (Pubitemid 36960042)
5. Yermilov V, Rubio J, Becchi M, Friesen MD, Pignatelli B and Ohshima H: Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 16: 2045-2050, 1995.
6. Kawanishi S, Hiraku Y, Pinlaor S and Ma N: Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387: 365-372, 2006.
7. Kawanishi S and Hiraku Y: Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8: 1047-1058, 2006. (Pubitemid 44036521)
8. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X and Kawanishi S: 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 14: 137-143, 2006. (Pubitemid 43165879)
9. Pinlaor S, Ma N, Hiraku Y, Yongvanit P, Semba R, Oikawa S, Murata M, Sripa B, Sithithaworn P and Kawanishi S: Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2′- deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis 25: 1535-1542, 2004. (Pubitemid 39162719)
10. Hoki Y, Hiraku Y, Ma N, Murata M, Matsumine A, Nagahama M, Shintani K, Uchida A and Kawanishi S: iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis. Cancer Sci 98: 163-168, 2007. (Pubitemid 44941867)
11. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 54: 8-29, 2004. (Pubitemid 38443417)
12. Weiss SW and Enzinger FM: Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41: 2250-2266, 1978. (Pubitemid 8370196)
13. Belal A, Kandil A, Allam A, Khafaga Y, El-Husseiny G, El-Enbaby A, Memon M, Younge D, Moreau P, Gray A and Schultz H: Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol 25: 16-22, 2002. (Pubitemid 34131022)
14. Randall RL, Albritton KH, Ferney BJ and Layfield L: Malignant fibrous histiocytoma of soft tissue: an abandoned diagnosis. Am J Orthop 33: 602-608, 2004.
15. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515, 1996. (Pubitemid 26330463)
16. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P and Oberhuber G: Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8: 1831-1837, 2002. (Pubitemid 34633742)
17. Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rossler K, Prodinger A, Budka H and Hainfellner JA: Expression of hypoxia-inducible factor-1α in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 92: 165-171, 2001. (Pubitemid 32623053)
18. Shintani K, Matsumine A, Kusuzaki K, Matsubara T, Satonaka H, Wakabayashi T, Hoki Y and Uchida A: Expression of hypoxia-inducible factor (HIF)-1α as a biomarker of outcome in soft-tissue sarcomas. Virchows Arch 449: 673-681, 2006. (Pubitemid 44832639)
19. Weiss SW and Goldbum JR: Enzinger and Weiss's Soft Tissue Tumors. 4th edition. Mosby Co., St. Louis, 2002.
20. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG and Morrow M (eds): AJCC Cancer Staging Manual. Springer, Berlin, 2002.
21. Pinlaor S, Hiraku Y, Ma N, Yongvanit P, Semba R, Oikawa S, Murata M, Sripa B, Sithithaworn P and Kawanishi S: Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 11: 175-183, 2004. (Pubitemid 39371095)
22. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47, 2002.
23. Semenza GL: Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35: 71-103, 2000.
24. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
25. Pinlaor S, Sripa B, Ma N, Hiraku Y, Yongvanit P, Wongkham S, Pairojkul C, Bhudhisawasdi V, Oikawa S, Murata M, Semba R and Kawanishi S: Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. World J Gastroenterol 11: 4644-4649, 2005. (Pubitemid 41179516)
26. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK and Lee SS: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 480-481: 243-268, 2001. (Pubitemid 32744832)
27. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466, 2004. (Pubitemid 39329586)
28. Loeb LA and Preston BD: Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 20: 201-230, 1986.
29. Wu X, Takenaka K, Sonoda E, Hochegger H, Kawanishi S, Kawamoto T, Takeda S and Yamazoe M: Critical roles for polymerase ζ in cellular tolerance to nitric oxide-induced DNA damage. Cancer Res 66: 748-754, 2006. (Pubitemid 43165938)